Promis Neurosciences Inc (TSE:PMN)’s share price dropped 8.3% on Tuesday . The stock traded as low as C$0.22 and last traded at C$0.22, approximately 155,780 shares traded hands during trading. A decline of 39% from the average daily volume of 254,484 shares. The stock had previously closed at C$0.24.
The firm has a 50 day simple moving average of C$0.22. The firm has a market cap of $65.35 million and a price-to-earnings ratio of -4.78.
Promis Neurosciences (TSE:PMN) last issued its quarterly earnings results on Tuesday, May 14th. The company reported C($0.01) earnings per share for the quarter. As a group, research analysts predict that Promis Neurosciences Inc will post 0.06 EPS for the current year.
About Promis Neurosciences (TSE:PMN)
ProMIS Neurosciences, Inc, a development stage biotech company, discovers and develops precision medicine therapeutics for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). Its proprietary target discovery engine is based on the use of two complementary techniques.
Featured Story: How does a 12b-1 fee affect fund performance?
Receive News & Ratings for Promis Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Promis Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.